Latest NewsNov 4, 2024HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases All Filter By: Year2024202320222021202020192018201720162015Jun 22, 2020HiFiBiO Therapeutics Presents Three Novel Immuno-Oncology Programs at 2020 AACR Virtual Annual Meeting IIMay 15, 2020HiFiBiO Therapeutics Unveils Several Novel Antibodies Showing Promise to Be Precision Immunotherapies for Cancer PatientsMar 30, 2020Droplet Microfluidic Screening and Sequencing Can Vastly Expand the Universe of New Antibody TherapeuticsJan 11, 2020Biotechs Build on Single-cell Analytics for Drug R&D, as Human Cell Atlas is MappedOct 28, 2019HiFiBiO Therapeutics Establishes World-Class Scientific Advisory Board< 1 … 10 11 12 13 14 … 17 >
